|
Volumn 151, Issue 4, 2012, Pages
|
[Omalizumab treatment in patients with asthma: summary of Meir Medical Center experience with 47 patients].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIASTHMATIC AGENT;
ANTIIDIOTYPIC ANTIBODY;
MONOCLONAL ANTIBODY;
OMALIZUMAB;
ADULT;
AGED;
ARTICLE;
ASTHMA;
FEMALE;
FORCED EXPIRATORY VOLUME;
HOSPITALIZATION;
HUMAN;
ISRAEL;
LUNG FUNCTION TEST;
MALE;
MIDDLE AGED;
PATHOPHYSIOLOGY;
RETROSPECTIVE STUDY;
STATISTICS;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-ASTHMATIC AGENTS;
ANTIBODIES, ANTI-IDIOTYPIC;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ASTHMA;
FEMALE;
FORCED EXPIRATORY VOLUME;
HOSPITALIZATION;
HUMANS;
ISRAEL;
MALE;
MIDDLE AGED;
RESPIRATORY FUNCTION TESTS;
RETROSPECTIVE STUDIES;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 84862253208
PISSN: 00177768
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|